BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 21047379)

  • 1. Discovery of pathway biomarkers from coupled proteomics and systems biology methods.
    Zhang F; Chen JY
    BMC Genomics; 2010 Nov; 11 Suppl 2(Suppl 2):S12. PubMed ID: 21047379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
    Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
    J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel alternative splicing biomarkers for breast cancer with LC/MS/MS and RNA-Seq.
    Zhang F; Deng CK; Wang M; Deng B; Barber R; Huang G
    BMC Bioinformatics; 2020 Dec; 21(Suppl 9):541. PubMed ID: 33272210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative proteomic analysis of different stages of breast cancer tissues using ultra high performance liquid chromatography tandem mass spectrometer.
    Al-Wajeeh AS; Salhimi SM; Al-Mansoub MA; Khalid IA; Harvey TM; Latiff A; Ismail MN
    PLoS One; 2020; 15(1):e0227404. PubMed ID: 31945087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival analysis in breast cancer using proteomic data from four independent datasets.
    Ősz Á; Lánczky A; Győrffy B
    Sci Rep; 2021 Aug; 11(1):16787. PubMed ID: 34408238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative membrane proteomics analyses of breast cancer cell lines to understand the molecular mechanism of breast cancer brain metastasis.
    Peng W; Zhang Y; Zhu R; Mechref Y
    Electrophoresis; 2017 Sep; 38(17):2124-2134. PubMed ID: 28523741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
    Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
    J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
    Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
    J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling.
    Pan S; Chen R; Crispin DA; May D; Stevens T; McIntosh MW; Bronner MP; Ziogas A; Anton-Culver H; Brentnall TA
    J Proteome Res; 2011 May; 10(5):2359-76. PubMed ID: 21443201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach.
    Beretov J; Wasinger VC; Millar EK; Schwartz P; Graham PH; Li Y
    PLoS One; 2015; 10(11):e0141876. PubMed ID: 26544852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic investigation on bio-corona of Au, Ag and Fe nanoparticles for the discovery of triple negative breast cancer serum protein biomarkers.
    Del Pilar Chantada-Vázquez M; López AC; Vence MG; Vázquez-Estévez S; Acea-Nebril B; Calatayud DG; Jardiel T; Bravo SB; Núñez C
    J Proteomics; 2020 Feb; 212():103581. PubMed ID: 31731051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma proteome profiling of a mouse model of breast cancer identifies a set of up-regulated proteins in common with human breast cancer cells.
    Pitteri SJ; Faca VM; Kelly-Spratt KS; Kasarda AE; Wang H; Zhang Q; Newcomb L; Krasnoselsky A; Paczesny S; Choi G; Fitzgibbon M; McIntosh MW; Kemp CJ; Hanash SM
    J Proteome Res; 2008 Apr; 7(4):1481-9. PubMed ID: 18311905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insight into the biological pathways underlying fibromyalgia by a proteomic approach.
    Ramírez-Tejero JA; Martínez-Lara E; Rus A; Camacho MV; Del Moral ML; Siles E
    J Proteomics; 2018 Aug; 186():47-55. PubMed ID: 30030163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
    Collins MA; An J; Hood BL; Conrads TP; Bowser RP
    J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detection.
    Fredolini C; Pathak KV; Paris L; Chapple KM; Tsantilas KA; Rosenow M; Tegeler TJ; Garcia-Mansfield K; Tamburro D; Zhou W; Russo P; Massarut S; Facchiano F; Belluco C; De Maria R; Garaci E; Liotta L; Petricoin EF; Pirrotte P
    Breast Cancer Res; 2020 Dec; 22(1):135. PubMed ID: 33267867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology.
    Cha S; Imielinski MB; Rejtar T; Richardson EA; Thakur D; Sgroi DC; Karger BL
    Mol Cell Proteomics; 2010 Nov; 9(11):2529-44. PubMed ID: 20739354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative proteomics, network analysis and post-translational modification identification reveal differential profiles of plasma Con A-bound glycoprotein biomarkers in gastric cancer.
    Uen YH; Lin KY; Sun DP; Liao CC; Hsieh MS; Huang YK; Chen YW; Huang PH; Chen WJ; Tai CC; Lee KW; Chen YC; Lin CY
    J Proteomics; 2013 May; 83():197-213. PubMed ID: 23541716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative proteomics study of breast cancer cell lines isolated from a single patient: discovery of TIMM17A as a marker for breast cancer.
    Xu X; Qiao M; Zhang Y; Jiang Y; Wei P; Yao J; Gu B; Wang Y; Lu J; Wang Z; Tang Z; Sun Y; Wu W; Shi Q
    Proteomics; 2010 Apr; 10(7):1374-90. PubMed ID: 20198662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a pharmaceutical hepatotoxicity biomarker panel using a discovery to targeted proteomics approach.
    Collins BC; Miller CA; Sposny A; Hewitt P; Wells M; Gallagher WM; Pennington SR
    Mol Cell Proteomics; 2012 Aug; 11(8):394-410. PubMed ID: 22527513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics analysis of human breast milk by two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) coupled with mass spectrometry to assess breast cancer risk.
    Aslebagh R; Whitham D; Channaveerappa D; Lowe J; Pentecost BT; Arcaro KF; Darie CC
    Electrophoresis; 2023 Jul; 44(13-14):1097-1113. PubMed ID: 36971330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.